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Activation of the transcription factor NF-kB is essen-
tial for innate immune function and requires strict
regulation. The micronutrient zinc modulates proper
host defense, and zinc deficiency is associated
with elevated inflammation and worse outcomes in
response to bacterial infection and sepsis. Previous
studies suggest that zincmay regulate NF-kBactivity
during innate immune activation, but a mechanistic
basis to support this has been lacking. Herein, we
report that the zinc transporter SLC39A8 (ZIP8) is a
transcriptional target of NF-kB and functions to
negatively regulate proinflammatory responses
through zinc-mediated down-modulation of IkB
kinase (IKK) activity in vitro. Accordingly, fetal fibro-
blasts obtained from Slc39a8 hypomorphic mice
exhibited dysregulated zinc uptake and increased
NF-kB activation. Consistent with this, mice pro-
vided zinc-deficient dietary intakes developed
excessive inflammation to polymicrobial sepsis in
conjunction with insufficient control of IKK. Our find-
ings identify a negative feedback loop that directly
regulates innate immune function through coordina-
tion of zinc metabolism.INTRODUCTION
The innate immune system constitutes the front line of host
defense by triggering inflammation, a primordial response de-
signed to protect the host against pathogen invasion (Takeuchi
and Akira, 2010). Upon recognition of pathogen-associated
molecular patterns, the Toll-like receptor (TLR) pathway
becomes activated in immune cells that include monocytes,
macrophages, dendritic cells, and nonprofessional cells such
as lung epithelia (Kawai and Akira, 2010). Inflammatory media-386 Cell Reports 3, 386–400, February 21, 2013 ª2013 The Authorstors are then rapidly released to further alert the remainder of
the immune system. TLR signaling initiates recruitment of
adaptor molecules such as TRIF, TIRAP, and MyD88 (Takeuchi
and Akira, 2010). In turn, the danger signal is transmitted coordi-
nately through a series of molecular events that involve the IRAK
family, TRAF6, and TAK1, leading to activation of IkB kinase (IKK)
and mitogen-activated protein kinases (MAPKs) (Hayden and
Ghosh, 2008; Johnson and Lapadat, 2002). Activation of the
IKK complex, which includes IKKa, IKKb, and NEMO, results in
IkB phosphorylation and degradation, thereby allowing phos-
phorylated NF-kB dimers to translocate into the nucleus and
bind kB sites located within target gene promoters for the activa-
tion of transcription (Hayden and Ghosh, 2008). Simultaneously,
activation of MAPKs upregulates ERKs, JNKs, and p38, leading
to the activation of the transcriptional factor AP-1 (Johnson and
Lapadat, 2002). IKKb can also activate ERKs through crosstalk
(Tpl2-MEK1/2) between the NF-kB and MAPKs/AP-1 pathways
(Banerjee et al., 2006; Waterfield et al., 2004).
Coordination of the initial host response to infection through
regulation of the NF-kB and MAPK pathways must be tightly
regulated in order to maintain proper immune balance, thereby
maximizing host defense while simultaneously minimizing collat-
eral damage (Liew et al., 2005). In order to achieve precise
balance, multiple counterregulatory elements have evolved
within these pathways that include but are not limited to IkBa
(Chiao et al., 1994), MyD88s (Burns et al., 2003), IRAKM (Ko-
bayashi et al., 2002), A20 (Boone et al., 2004), and NLRC5 (Cui
et al., 2010). The expression and function of many of these nega-
tive regulators including IkBa, A20, MyD88s, and IRAKM are
themselves activated by TLR ligands and thus constitute classic
negative regulatory feedback loops that ensure attenuation of
the TLR response in a threshold-dependent manner (Ruland,
2011).
Sepsis is the leading cause of death in critically ill patients in
the United States (Angus et al., 2001), and its incidence has
increased over the past two decades (Martin et al., 2003). A
major cause of sepsis-related morbidity and mortality is over-
whelming inflammation, referred to as the ‘‘cytokine storm,’’
driven by the excessive production of inflammatory mediators
Figure 1. SLC39A8 Expression Is Induced by Proinflammatory Stimuli in an NF-kB-Dependent Manner and Regulates Zinc Uptake
(A) Human primary lung epithelia were treated with TNF-a (10 ng/ml) for 16 hr (n = 3), human primarymonocytes were treatedwith LPS (1 mg/ml) for 4 hr (n = 4), and
CD14+ monocyte-derived primary macrophages were treated with LPS (1 mg/ml) for 6 and 24 hr. SLC39A8 mRNA levels were determined by real-time PCR
analysis. Relative CN, RCN. Western blot was performed on membrane fractions with ZIP8 antiserum. Immunofluorescence staining shows ZIP8 localization
(green) in macrophages, counterstained with DAPI (scale bar, 10 mm). Ctrl, control.
(B) THP1 cells were treated with LPS (1 mg/ml) for 4 hr with Bay11-7082 (20 mM), added 30 min prior to LPS.
(C) A549 cells were treated with TNF-a (10 ng/ml) in combination with RELA siRNA (40 pmol), which was transfected 24 hr before TNF-a treatment.
(legend continued on next page)
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within hours of pathogen invasion (Hotchkiss and Karl, 2003;
Warren, 1997). The magnitude of the innate immune response
to infection directs the cumulative host response with respect
to tissue injury and survival (Abraham and Singer, 2007).
Importantly, patients with sepsis who encounter an exaggerated
initial inflammatory response are more susceptible to tissue
injury and mortality, but it remains unclear why or how this
occurs (Parrillo, 1993).
Zinc, an essential trace element, facilitates the coordination of
innate and adaptive immunity (Rink and Haase, 2007). Zinc defi-
ciency causes immune dysfunction resulting in increased
morbidity and mortality following infection (Caulfield et al.,
2004), whereas zinc supplementation prevents the incidence of
infectious diseases and improves immune function (Brooks
et al., 2005; Prasad et al., 2007). Zinc metabolism is primarily
coordinated by zinc transporters. In mammals, these transmem-
brane-spanning proteins are encoded by two solute-linked
carrier (SLC) gene families that include 14 SLC39 (also known
as ZIP) family members and 10 SLC30 (aka ZnT) family
members. SLC39 transporters increase cytosolic zinc content
by promoting extracellular uptake or release from subcellular
organelles, whereas SLC30 transporters function as counterre-
gulators that decrease intracellular zinc levels (Lichten and
Cousins, 2009).
Despite recent advances (Aydemir et al., 2009; Kitamura et al.,
2006; Nishida et al., 2009; Yu et al., 2011), much remains
unknown regarding the influence of zinc transporters on zinc
metabolism relative to innate immunity (Lichten and Cousins,
2009). Zinc metabolism changes rapidly in response to systemic
infection in humans, leading to rapidmobilization of intravascular
zinc into vital organs with a consequent decrease in circulating
plasma zinc levels (hypozincemia) (Cousins and Leinart, 1988;
Gaetke et al., 1997; Sobocinski et al., 1978). Zinc redistribution
is primarily driven by induction of key zinc transporters, as exem-
plified by the upregulation of Slc39a14 (ZIP14) mediated by IL-6
(Liuzzi et al., 2005). Importantly, lower-than-expected circulating
zinc levels correlate with higher mortality in humans with sepsis
(Wong et al., 2007), although the consequences of altered zinc
metabolism in this setting are not yet known.
Using a mouse model of polymicrobial sepsis, we reported
that zinc deficiency increases systemic inflammation and
mortality, whereas zinc supplementation suppresses inflamma-
tion and improves survival, suggesting that zinc metabolism
plays an important regulatory role during the early stage of
sepsis (Bao et al., 2010; Knoell et al., 2009). Our group and others
have identified SLC39A8 (ZIP8) as the most significantly upregu-
lated transporter in response to cytokines, bacteria, and sepsis,
suggesting its unique role in innate immune function (Begum
et al., 2002; Besecker et al., 2008; Besecker et al., 2011). Herein,
we report that ZIP8 is a negative feedback regulator of NF-kB
and innate immune activation in response to infection through
coordination of zinc metabolism. These findings help to bridge(D) Control siRNA or SLC39A8 siRNA-treated THP1 cells were stimulatedwith LPS
by flow cytometry. MFI, mean fluorescence intensity. Representative composite
served as a positive control. Two representative FluoZin-3 staining images are sho
(E) Total zinc levels in culture medium and cell pellets were detected by AAS or I
Data are presented as mean ± SD. *p < 0.05. See also Figure S1.
388 Cell Reports 3, 386–400, February 21, 2013 ª2013 The Authorsan existing gap in our fundamental understanding of how zinc
affects innate immunity and host defense.
RESULTS
Proinflammatory Stimuli Induce SLC39A8 Expression in
an NF-kB-Dependent Manner, Resulting in Zinc Influx
SLC39A8 expression is upregulated in primary human lung
epithelia, monocytes, and macrophages in response to TNF-
a or lipopolysaccharide (LPS). SLC39A8 (ZIP8) protein localizes
mainly to the plasmamembrane, in addition to lysosomal ormito-
chondrial membranes (Aydemir et al., 2009; Besecker et al.,
2008). ZIP8 is heavily glycosylated following stimulation, leading
to increased expression of a high molecular weight, membrane-
associated protein (Figures 1A, and Figures S1A, and S1B),
suggesting that additional posttranscriptional (or translational)
regulatory events are at play in controlling protein function (that
will require further study). Mouse Slc39a8 possesses 89%amino
acid sequence and 96% ZIP domain sequence identity with
human SLC39A8, implying a high degree of conservation (Girija-
shanker et al., 2008). As expected, LPS also induced Slc39a8
expression in mouse RAW 267.4 cells (Figure S1C). We next
examined whether SLC39A8 expression is NF-kB dependent.
Suppression of NF-kB by pharmacologic inhibition or RELA-
specific siRNA significantly inhibited SLC39A8 expression
induced by LPS or TNF-a (Figures 1B and 1C).
Because ZIP8 is a zinc importer, we then determined whether
changes in ZIP8 expression result in changes in intracellular zinc
content. Using the cell-permeable zinc indicator FluoZin-3, we
revealed that intracellular labile zinc levels rapidly increased in
response to LPS but was significantly impaired in ZIP8-silenced
cells (Figure 1D), indicating that ZIP8 plays an important role in
regulating zinc uptake shortly following TLR activation. The
representative pictures depict the unique pattern of intracellular
labile zinc. We further observed a decrease in total zinc content
in the culture mediumwith a corresponding increase within cells,
establishing that elevation of intracellular labile zinc content
occurs following transport across the plasma membrane via
ZIP8 (Figure 1E). As expected, we also observed a significant
increase in intracellular labile zinc levels when ZIP8 was overex-
pressed (Figure S1D).
SLC39A8 Transcription Is Directly Regulated by NF-kB
Inspection of the human SLC39A8 gene sequence revealed four
potential transcript variants, indicating that its transcription may
be initiated atmultiple transcriptional start sites (TSSs). Based on
this, 50RACE (rapid amplification of cDNA ends) was conducted
and revealed two TSSs, but only one was induced by TNF-a
(Figures S2A–S2C). The inducible TSS was in close proximity
to the known TSS of the reference sequence (NM_022154.5).
Based upon their close proximity, the known TSS served as
the basis of subsequent studies (Aiba et al., 2008).(1 mg/ml), followed by FluoZin-3 staining. Intracellular labile zinc was quantified
flow cytometric histograms are shown, and ZnSO4 (10 mM)/pyrithione (10 mM)
wn (scale bar, 10 mm). Western analysis of ZIP8 silencing is shown in Figure 3A.
CP-OES, respectively.
Figure 2. Transcriptional Activation of the Human SLC39A8 Promoter by NF-kB
(A) Schematic diagram depicts a 2 kb SLC39A8 promoter region and its serial deletion constructs that were cloned into a pGL3-Basic vector.
(B) Sequence of the key promoter region and four potential putative NF-kB-binding sites.
(C) Constructs were transfected into A549 cells, followed by TNF-a (10 ng/ml) treatment for 24 hr. Serial deletion identified kB2 as the critical binding site. The
NF-kB reporter 3 3 kB-luc served as the positive control. Site-directed mutagenesis of the kB2 site resulted in the loss of promoter activity.
(D) Ectopic expression of p65, but not p50, induced promoter activity of the 130 bp construct, which was further inhibited by IkBa-SR. Moreover, a mutated
construct (130-bp_Mut) was not responsive to p65.
(E) ChIP-based PCR analysis of p65-bound chromatin DNA, which was immunoprecipitated from THP1 cells treated with vehicle or LPS (1 mg/ml) for 1 hr. A
234 bp band containing kB2 was amplified from the SLC39A8 promoter region. The adjacent region devoid of kB2 was amplified as a negative control. CCL2
served as a positive control.
(legend continued on next page)
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NF-kB activates gene transcription following physical interac-
tion with the kB-binding motif located within the regulatory
region of target genes. Analysis of the human SLC39A8 gene
(Match) revealed five potential putative kB-binding sites in the
50-flanking region (Figure 2A). The sequences of kB 1–4 are
shown in Figure 2B. To determine whether the kB sites are tran-
scriptionally active, a 2 kb promoter fragment (1,881 to +120) of
human genomic DNA was amplified and cloned into a pGL3
luciferase reporter. A series of plasmids with progressively trun-
cated promoter regions were subsequently developed and used
to locate a 100 bp region proximal to the TSS, containing kB 1–4,
which was required for promoter activity (Figures 2A and 2C).
Serial deletion of kB regions 1–4 identified kB2 as the critical
binding site. Loss of kB2 resulted in a decrease of both con-
stitutive and inducible activity (Figures 2C and S2D). Ectopic
expression of p65 also induced kB2-mediated expression,
whereas the IkBa superrepressor (SR) inhibited induction (Figure
2D). Confirmation of the kB2 site was achieved by site-directed
mutagenesis (Figures 2C and 2D). Chromatin immunoprecipita-
tion (ChIP) analysis demonstrated in vivo binding of NF-kB p65
to the SLC39A8 promoter region, and EMSA analysis revealed
physical binding of kB2 oligonucleotides with activated NF-kB
(p65) in vitro (Figures 2E, 2F, S2E, and S2F).
ZIP8 Is a Potent Negative Regulator of NF-kB Activation
Transcriptional induction of ZIP8 by NF-kB revealed that ZIP8
may assist in coordination of host defense. We first determined
the extent of immune activation following ZIP8 knockdown in
human monocytes and lung epithelia. Under all conditions
studied, suppression of ZIP8 expression resulted in increased
production of proinflammatory mediators (cytokines) (Figures
3A, 3B, S3A, S3B, and S3E). Consistent with this, endogenous
NF-kB-binding activity was higher when ZIP8 expression was
silenced in THP1 cells (Figure S3D). We then screened signaling
effectors of the NF-kB and MAPK pathways (Figures 3C and
S3C). Suppression of ZIP8 expression increased phosphoryla-
tion of p65 and IkBa, two known substrates of IKKb, suggesting
that ZIP8 affects the activity of the IKK complex. An increase in
p-ERK, p-Akt, and A20 levels was also observed. The minor
change observed in phosphorylation of IKKa/b indicated that
ZIP8 suppression did not significantly impact the activity of IKK
upstream signaling intermediates. Consistent with this, IRAK1
was degraded with similar kinetics in both control and ZIP8-
silenced cells. No appreciable differences in JNK phosphoryla-
tion were observed. We then immunoprecipitated the IKK
complex and directly measured its activity. Suppression of
ZIP8 significantly increased IKK activity in response to LPS,
thereby providing evidence that ZIP8-mediated effects occur
at or proximal to IKK (Figure 3D). Consistent with its role as
a negative regulator, we observed that overexpression of ZIP8
inhibits NF-kB activation induced by TNF-a or IL-1b (Figures
3E and S3F). Knowing that overexpression of MyD88, TRAF6,
IKKb, or p65 induces NF-kB (Cui et al., 2010), we cotransfected(F) EMSA revealed the binding of biotin-labeled kB2 with nuclear extracts from T
oligonucleotides (103 and 1003 ). Coincubation with a p65 antibody produced a
a positive control.
Data are presented as mean ± SD. *p < 0.05; n.s., not significantly different. See
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sion of ZIP8 with either MyD88, TRAF6 or IKKb, but not p65, in-
hibited NF-kB activation, indicating that the location of the ZIP8
effect is at or upstream of IKKb (Figures 3F and S3G). Taken
together, these findings strongly indicate that ZIP8 negatively
regulates NF-kB through down-modulation of IKK. Additionally,
we observed that augmentation of NF-kB activation by ZIP8
knockdown was reduced by the addition of zinc in combination
with pyrithione, an ionophore that facilitates zinc entry into the
cytosol (Figure 3G). This observation led us to then determine
whether the negative regulatory impact of ZIP8 on NF-kB is
dependent on zinc.
Zinc Suppresses NF-kB Activation through Direct
Interaction with IKK
Zinc is known to inhibit NF-kB activation, but the underlying
mechanism remains unclear (Haase and Rink, 2009; Jeon
et al., 2000). We observed that zinc significantly inhibited the
expression of NF-kB-dependent transcripts or luciferase
reporter (Figures S4A and S4B). The phosphorylation of IkBa
was markedly inhibited, and degradation of IkBa was nearly
abolished, resulting in a significant reduction in p65 nuclear
translocation. A significant time-dependent inhibition of IKK
activity was also observed (Figure 4A). Meanwhile, zinc was
not found to inhibit the activity of the E3 ligase SCFb-TrCP
complex that mediates IkBa ubiquitination and degradation
(data not shown). We also observed that zinc inhibited NF-kB
activity driven by overexpression of MyD88, TRAF6, and IKKb,
but not p65, mapping the location of the effect at IKK, identical
to our previous findings involving ZIP8 cotransfection (Fig-
ure S4B). Given the remarkable similarity between ZIP8- and
zinc-mediated effects that identified IKK complex as the target,
we next determined whether zinc directly binds to and inhibits
IKK. First, we observed that recombinant IKKa or IKKb was
directly inhibited by zinc in a dose-responsive manner (IC50 for
IKKa: 0.52 mM [95% CI 0.42–0.64 mM]; IC50 for IKKb: 0.43 mM
[95% CI, 0.32–0.58 mM]) (Figure 4B). To understand whether
zinc selectively inhibits IKKa and/or IKKb, we exposed IKKb(/)
mouse embryonic fibroblasts (MEFs) to IL-1b and evaluated
NF-kB-mediated function. As expected, IKKb(/) cultures ex-
hibited impaired NF-kB activation and were less responsive to
IL-1b when compared to IKKb(+/+) cultures (Li et al., 1999). In
particular, zinc/pyrithione inhibited IkBa phosphorylation and
degradation as well as IL-6 production in IKKb(+/+) cells, whereas
these effects were attenuated in IKKb(/) cultures (Figures 4C
and S4C). Although recombinant IKKa was inhibited by zinc,
IKKb(/) MEFs that contain IKKa did not exhibit zinc-mediated
inhibition, indicating that the primary effect of zinc occurs directly
through inhibition of IKKb and/or IKKb-related kinase complex
formation. We also conducted similar experiments in NEMO(/)
MEFs but did not observe zinc-mediated effects because
cultures were completely unresponsive to proinflammatory cyto-
kines (data not shown) (Rudolph et al., 2000).NF-a-treated A549 cells. Binding was inhibited by an excess of unlabeled kB2
supershift. The biotin-labeled NF-kB consensus sequence (ConkB) served as
also Figure S2.
Figure 3. ZIP8 Modulates NF-kB Activity and the Inflammatory Response
(A and B) THP1 cells were transfected with either scrambled control or SLC39A8 siRNA for 3 days, followed by LPS (1 mg/ml3 6–12 hr) treatment. ZIP8 silencing
was evaluated by western analysis. Cytokine levels in culture medium were determined by ELISA at 6 hr.
(C) Western blot analysis of signaling molecules in THP1 extracts following ZIP8 knockdown in combination with LPS treatment. P, phosphorylated.
(D) IKK activity was measured following IP of the IKK complex using an anti-iKKb antibody.
(E) ZIP8 overexpression inhibits NF-kB activation induced by TNF-a or IL-1b. HEK293 cells were transfected with 33 kB-luc and ZIP8 cDNA construct, followed
by treatment with TNF-a (10 ng/ml) or IL-1b (20 ng/ml) for 24 hr.
(legend continued on next page)
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Next, we observed that zinc directly binds to IKKb (Figures 4D
and S4D). Based on this, we then immunoprecipitated the IKK-
b-associated protein complex from LPS-stimulated cultures
and treated immunoprecipitates with the zinc-specific chelator
TPEN to remove protein-bound zinc. TPEN chelation resulted
in an increase of kinase activity, substantiating that zinc directly
binds to IKK intracellularly and inhibits kinase activity (Fig-
ure S4E). Furthermore, using confocal microscopy, we observed
that overexpressed dsRed-tagged IKKb partially colocalized
with intracellular labile zinc, further supporting a direct interac-
tion between labile zinc and IKKb within the cytosol (Figures 4E
and S4F). The crystal structure of IKKb (Xenopus laevis) has
recently been reported by Xu et al. (2011). A human IKKb proto-
mer model was constructed based on homology modeling.
Accordingly, we utilized a combination of in silico modeling
and site-directed mutagenesis and revealed a zinc coordination
site located at His 143. Strikingly, this coordination site resides
within the C lobe of the kinase domain, which is critical for
IKKb catalytic activity and responsiveness to zinc-mediated inhi-
bition (both human and mouse). The structural model predicts
that the coordination site is comprised of the zinc-binding
residues H137, H143, D204, and I141 (Figures 4F, 4G, and
S4G–S4I). In contrast, mutation of H313 located within the ubiq-
uitin-like domain (ULD), at a potential alternative zinc coordina-
tion site identified by our screening approach, did not alter
zinc-mediated kinase inhibition, indicating that zinc does not
impact kinase activity through a ULD-related interaction. Collec-
tively, our findings reveal that ZIP8-mediated zinc transport is
critical in attenuating NF-kB signaling through zinc-mediated
inhibition of IKKb kinase activity.
Zinc Deficiency Augments IKK Activity and the
Inflammatory Response In Vivo
We recently reported that moderate zinc deficiency significantly
increased systemic inflammation, tissue injury, and mortality in
response to polymicrobial sepsis (Bao et al., 2010; Knoell
et al., 2009). Having established that zinc inhibits NF-kB activa-
tion through IKKb in vitro, we postulated that systemic zinc
deficiency in mice would result in elevated inflammation that
would correlate with insufficient control of IKK signaling. To
test this hypothesis, adult mice were first administered a zinc-
deficient diet for 3 weeks, followed by LPS injection or cecal liga-
tion and puncture (CLP) treatment for 2 hr. Animals maintained
on a zinc-deficient diet had a significant decrease in zinc levels
in the serum, peripheral monocytes, and lung (Figures 5B and
5C) (Knoell et al., 2009). In response to CLP, zinc-deficient
mice also exhibited a significant increase in serum proinflamma-
tory cytokines (IL-6, KC, TNF-a, andMCP-1) and lung transcripts
of NF-kB target genes when compared to their normal dietary
counterparts, indicative of an elevation in NF-kB activation
(Figures 5A and 5D). A significant increase of phosphorylated
IkBa and IkBa degradation was also observed in the lung,(F) HEK293 cells were transfected with MyD88, TRAF6, IKKb, or p65 expression
activity was measured 24 hr after transfection.
(G) Zinc addition normalized the extent of NF-kB activation in the cells subject
(1 mg/ml) treatment for 8 hr. Zinc (5 mM) and pyrithione (5 mM) were added 30 mi
Data are presented as mean ± SD. *p < 0.05. See also Figure S3.
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deficiency. ERK phosphorylation was also increased, whereas
alterations in JNK phosphorylation were nominal (Figure 5E).
Similar results were observed with LPS-exposed animals
(Figures S5A–S5C) and an in vitro monocyte cell line model in
which cells were grown in zinc-deficient medium (Figure S5D).
ZIP8 Is Upregulated and Correlates with Altered Zinc
Metabolism In Vivo in Response to LPS and Sepsis
Based upon in vitro studies, we sought to determine whether the
upregulation of ZIP8 could be recapitulated in vivo. A significant
increase in ZIP8 mRNA and protein expression was observed in
lung tissue in response to both CLP and endotoxin. Expression
was localized to alveolar epithelia, upper-airway epithelia, and
alveolar macrophages (Figures 6A–6C and S6A). Slc39a8
expression did not change in the liver (data not shown); however,
expression of Slc39a14 (ZIP14), the closest homolog to Slc39a8,
was upregulated in the liver (Figure S6B) (Liuzzi et al., 2005) but
did not change in the lung (data not shown). At the same time,
plasma zinc levels precipitously declined following LPS and
CLP challenge, consistent with hypozincemia, in the absence
of body zinc loss (Cousins and Leinart, 1988). In sharp contrast,
zinc levels in the lung and liver increased. Also, consistent with
human studies (Gaetke et al., 1997), plasma zinc levels began
to recover toward baseline within 16 hr following LPS challenge.
CLP resulted in persistent hypozincemia and accumulation of
zinc in the lung and liver, presumably as a consequence of
increased and prolonged systemic inflammation (Figures 6D,
S6C, and S6D). Accordingly, an increase in tissue metallothio-
nein was observed in the lung and liver in response to LPS and
CLP treatment, which could result from zinc influx, inflammation,
or both (Figures 6E and S6E). CLP also significantly increased
both ZIP8 expression and intracellular zinc content in circulating
monocytes (Figure 6F).
Slc39a8HypomorphicMouse Fetal Fibroblasts AreMore
Responsive to Proinflammatory Cytokines
Obliteration of ZIP8 is embryo lethal precluding in vivo validation
studies in Slc39a8-knockout mice. In lieu of this, we conducted
studies in Slc39a8 hypomorphic mice that harbor a Slc39a8(neo)
allele that contains the neomycin-resistance gene (neo) in intron
3. Homozygous Slc39a8(neo/neo) mice have a significant reduc-
tion in ZIP8 mRNA and protein levels (>90%) and diminished
zinc levels in vital tissues. Due to developmental defects, the
Slc39a8(neo/neo) homozygotes die between GD18.5 and 48 hr
postnatally (Ga´lvez-Peralta et al., 2012; Wang et al., 2011).
In order to examine the function of ZIP8, we generated mouse
fetal fibroblasts (MFFs) from GD16.5 Slc39a8(+/+), Slc39a8(+/neo),
and Slc39a8(neo/neo) mice. As expected, Slc39a8(neo/neo) MFFs
had significantly diminished ZIP8 mRNA and protein levels
compared to that in Slc39a8(+/+) and Slc39a8(+/neo) cells. Metallo-
thionein (Mt1) expression was also decreased in Slc39a8(neo/neo)plasmids together with the ZIP8 cDNA and 3 3 kB-luc constructs. Luciferase
ed to ZIP8 knockdown. siRNA knockdown was performed, followed by LPS
n prior to LPS.
Figure 4. Zinc Inhibits NF-kB Activation through IKK
(A) Zinc (10 mM)/pyrithione (10 mM), added 30 min prior to TNF-a (10 ng/ml), inhibits NF-kB activation in A549 cells: western blot analysis (Figure S4A shows the
entire blot); immunofluorescent staining of p65 at 30 min after TNF-a treatment (scale bar, 10 mm); IKK activity following IP of the IKK complex.
(B) Zinc inhibits human recombinant IKKa and IKKb activity in a dose-dependent manner.
(C) Effect of zinc on IKKb(/) MEFs. IKKb(/) and IKKb(+/+) MEFs were treated with zinc (10 mM)/pyrithione (2 mM) for 30 min, followed by IL-1b (200 ng/ml)
treatment. IL-6 was measured in culture medium by ELISA at 6 hr. Western analysis was performed on samples at 30 min after IL-1b treatment.
(D) A 65Zn-blotting assay was performed to evaluate zinc binding with IKKb. Samples include recombinant IKKb (cleaved and intact GST fusion) and native IKKb
that was immunoprecipitated from TNF-a-treated A549 cells.
(E) Confocal image analysis identified colocalization of reconstituted IKKb-dsRed and zinc (FluoZin-3, green). IKKb(/) MEFs were treated with IL-1b (100 ng/ml)
for 4 hr. Figure S4F shows the images in multiple channels.
(F) Dose-response curves of zinc inhibition on IKKb and corresponding mutants. The IC50 values are shown on the right.
(legend continued on next page)
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cultures, most likely as a consequence of decreased intracellular
zinc levels (Figure 7A). A time-dependent analysis of zinc content
in culture medium revealed that Slc39a8(neo/neo) MFFs are
impaired in their ability to uptake zinc in response to TNF-a
(Figure 7B). We then examined the inflammatory response of
MFFs to TNF-a and IL-1b. Slc39a8(neo/neo) MFFs produced
more IL-6, compared with that in Slc39a8(+/neo) and Slc39a8(+/+)
cells (Figures 7C and S7B), and consistently showed increased
transcript levels of NF-kB-driven genes (Figures 7D, S7A, S7C,
and S7D). Strikingly, the signaling events demonstrate that the
presence of phosphorylated p65 and IkBa is elevated in
Slc39a8(neo/neo) MFFs, in tandem with prolonged IkBa degrada-
tion. These findings are also consistent with elevated IKKb
activity, thereby further corroborating that ZIP8 negatively regu-
lates NF-kB through IKKb (Figure 7E).
DISCUSSION
Overwhelming bacterial infection quickly activates the innate
immune response and triggers inflammation in order to enable
host defense. The magnitude of the initial response must be
agile, relative to the type and extent of infection, to facilitate
pathogen removal, extinguish inflammation, and ultimately
restore homeostasis. Indeed, in the words of Lewis Thomas,
‘‘Our arsenals for fighting off bacteria are so powerful, and
involve so many different defense mechanisms, that we are in
more danger from them than from the invaders’’ (Thomas,
1972). Consistent with his postulate, patients with sepsis typi-
cally do not succumb to the initial infection but rather succumb
later to immune dysfunction, end-organ damage, and secondary
infection. Mortality from sepsis and septic shock is strongly
associated with overactivation of the initial inflammatory
response (Abraham and Singer, 2007). Increased expression of
NF-kB-driven cytokines, including TNF-a, IL-1b, and IL-6, is
associated with increased risk for vital organ failure and a worse
prognosis (Hotchkiss and Karl, 2003), but it is still not knownwhy
immune imbalance occurs.
Multiple negative feedback pathways have evolved to control
the extent of innate immune activation (Ruland, 2011). Herein, we
report a unique negative feedback regulator, ZIP8, that directly
couples zinc metabolism to the regulation of innate immunity.
ZIP8 shares a similar feature with other established NF-kB-nega-
tive feedback regulators, including IkBa (Chiao et al., 1994) and
A20 (Boone et al., 2004), in that its expression requires activation
by the very pathway it controls; however, ZIP8 is unique in that its
function is coupled to the importation of zinc. Furthermore, ZIP8
functions by guiding zinc into the cytosol to inhibit IKKb, thereby
regulating immune balance. Zinc directly binds to a coordination
site in IKKb that includes H143 within the kinase domain.
Because H143 together with D145 and Mg2+ are known to coor-
dinate ATP binding, we predict that zinc interaction with H143
will result in a rotameric switch that weakens ATP binding,
thereby reducing or inactivating IKKb enzyme activity, although(G) Model of zinc coordination in the kinase domain of human IKKb. Left view is
N andC lobe of the kinase domain (pink and red, respectively), the ULD (blue), and
zinc-binding site in the C lobe of the kinase domain. On the right is a magnified v
Data are presented as mean ± SD. *p < 0.05. See also Figure S4.
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a critical switch for activating the ERK signaling pathway (Bane-
rjee and Gerondakis, 2007). Consistent with this, we observed
that ZIP8-mediated zinc transport inhibited ERK signaling. The
function of zinc in concert with ZIP8 on NF-kB is conserved in
different cell types, including monocytes, macrophages, and
lung epithelial cells. Consistent with this, loss of the zinc exporter
Slc30a5 (Znt5) in mast cells resulted in increased labile zinc and
suppressed NF-kB signaling in response to FcεRI stimulators
(Nishida et al., 2009). However, it is important to recognize that
zinc function and trafficking are highly dependent on the cell
type within the context of cell activation. For example, TLR4
stimulation in dendritic cells decreases cytosolic-free zinc
through the suppression of ZIP6 (Kitamura et al., 2006). T cell
(CD3+) activation upregulates ZIP8, which promotes labile zinc
release from the lysosome and enhances IFN-g production
(Aydemir et al., 2009). TCR activation in CD4+ T cells induces
zinc influx through ZIP6, resulting in augmentation of TCR
signaling (Yu et al., 2011). These important findings underscore
the complexity of zinc metabolism relative to immune function.
Humans and bacteria, in many respects, are engaged in a ‘‘tug
of war’’ at the host-microbial interface and compete for vital
resources to maintain essential biological functions (Kehl-Fie
and Skaar, 2010). We speculate that zinc, typically abundant
within the extracellular milieu, is a vital commodity at the onset
of infection and that ZIP8 plays a vital role to uptake zinc into
host cells thereby providing a competitive advantage. Zinc
metabolism and turnover in humans are relatively high, with
approximately 1% of total body zinc content replenished daily
by the diet (King et al., 2000). In cells, a labile zinc pool is rapidly
exchangeable and altered in response to zinc conditions as well
as to extracellular stimuli. Labile zinc regulates signaling, through
both kinases and phosphatases, and its levels are maintained by
zinc transporters (Haase and Rink, 2007). Recent elucidation of
ZIP protein structure has revealed that zinc transport is a nonsa-
turable and electrogenic process consistent with features of
a zinc-permeable channel (Lin et al., 2010), a model distinct
from conventional ATP or voltage-gated transport, indicating
that expression of ZIPs is coupled to functional control. More-
over, as we reveal, ZIP8 is directly regulated by NF-kB at the
transcriptional level, making it unique and highly specialized to
allow the rapid sequestration of zinc in response to infection.
Similar to ZIP8, ZIP14 is regulated by IL-6-dependent signaling
in the liver (Liuzzi et al., 2005). Phylogenetic analysis of SLC39
family proteins reveals that ZIP8 and ZIP14 are related and
distinct from the other 12 ZIPs (Girijashanker et al., 2008). This
is intriguing when taking into account that both genes emerged
in land animals from a single gene in sea animals approximately
420 million years ago. This evolutionary divergence supports the
notion that specialized zinc transporter function(s) may have
evolved as a consequence of new environmental pressures. As
driven in part by ZIP8 and ZIP14, hypozincemia is a well-charac-
terized phenomenon that occurs in response to systemicthe computationally derived model of the human IKKb protomer, including the
the scaffold/dimerization domain (dark green). Highlighted in bright green is the
iew of the zinc-binding site and contributing binding residues.
Figure 5. Systemic Zinc Deficiency Increases the Proinflammatory Response to Sepsis
(A) Cytokine analysis of serum obtained from mice that were maintained on zinc-deficient or corresponding control diet for 3 weeks, followed by CLP. Samples
were obtained 2 hr after CLP. Zn, zinc; Zn, zinc deficient; Ctrl/CLP: control (normal) diet plus CLP; Zn/CLP, zinc-deficient diet plus CLP.
(B) Labile zinc levels in peripheral blood monocytes at 2 hr after CLP. Figure 6F describes the methodology.
(C) Total zinc levels in the lung at 2 hr after CLP, as measured by AAS.
(D) Gene expression analysis of NF-kB target genes in mouse lung tissues.
(E) Total proteins were extracted from lung and subjected to western analysis. Densitometry is presented as a histogram to the right.
Data are presented as mean ± SEM. *p < 0.05. See also Figure S5.
Cell Reports 3, 386–400, February 21, 2013 ª2013 The Authors 395
Figure 6. Endotoxin or Sepsis Induces Slc39a8 Expression Resulting in Increased Zinc Levels in Lung and Monocytes
(A) Slc39a8 expression was induced in mouse lung following CLP treatment.
(B) Western blot analysis shows the induction of ZIP8 protein in whole-lung homogenates 24 hr after CLP.
(C) Immunostaining shows that ZIP8 expression is increased at 24 hr following LPS or CLP treatment in alveolar epithelia, upper-airway epithelia, and alveolar
macrophages (scale bars, 20 mm for 4003 and 10 mm for 1,0003 magnification).
(legend continued on next page)
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Figure 7. Slc39a8 Hypomorphic MFFs Have
an Elevated Proinflammatory Response to
TNF-a
(A) Real-time PCR quantified the mRNA levels of
ZIP8 and MT1 in Slc39a8(+/+), Slc39a8(+/neo), and
Slc39a8(neo/neo) primary MFFs cultures. Western
analysis shows ZIP8 protein levels.
(B) Total zinc levels in culture medium were
determined by AAS.
(C) Slc39a8(+/+), Slc39a8(+/neo), and Slc39a8(neo/neo)
MFFs were treated with mouse TNF-a (50 ng/ml)
for the indicated time. IL-6 levels weremeasured in
the culture supernatants.
(D) Analysis of proinflammatory gene expression
profiles in Slc39a8(+/+), Slc39a8(+/neo), and
Slc39a8(neo/neo) MFFs that were treated with
TNF-a for the indicated time points. Data are
presented as a representative heatmap following
normalization to untreated group. Gene designa-
tion is to the right of each row.
(E) Western blot analysis of signaling pathways in
Slc39a8(+/+) and Slc39a8(neo/neo)MFFs treated with
TNF-a.
Data are presented as mean ± SD. *p < 0.05.
See also Figure S7.infection and inflammation (Cousins and Leinart, 1988; Gaetke
et al., 1997; Sobocinski et al., 1978). Based on our findings
that correlate with in vivo observations, we propose that ZIP8
and ZIP14 are unique zinc transporters that are rapidly induced
in a tissue-specific manner, thereby channeling zinc to funda-(D) Time-lapse analysis of zinc levels in serum and lung tissue, following CLP exposure.
(E) Metallothionein (MT) staining in the lung 24 hr after LPS or CLP (scale bar, 20 mm).
(F) Mouse peripheral leukocytes were stained with CD115-APC and F4/80-Pacific Blue, along with FluoZin-3
Monocytes were selected as CD115+/F4/80+ cells, followed by histogram analysis of FluoZin-3 or FITC-posit
zinc or ZIP8 were compared, based on MFI.
Data are presented as mean ± SEM. *p < 0.05. See also Figure S6.
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points that help to coordinate and
balance host defense.
Zinc deficiency is a significant health
care problem (Hambidge and Krebs,
2007) and a leading cause of infections
including pneumonia, diarrhea, and ma-
laria (Caulfield et al., 2004). Rapid
changes in zinc metabolism that lead to
hypozincemia are common in critically ill
patients. Septic shock nonsurvivors
have lower serum zinc levels, compared
with survivors who are able to recover
from hypozincemia (Wong et al., 2007).
In adult septic subjects, lower plasma
zinc levels correlated with higher ZIP8
expression levels in monocytes, higher
cytokine levels, and increased organ
damage within the first 24 hr following
ICU admission (Besecker et al., 2011).
Based upon these observations, it isplausible that prolonged hypozincemia and elevated ZIP8
expression in monocytes might be useful prognostically as
a guide for zinc supplementation in patients with sepsis. Zinc
supplementation has been shown to prevent the incidence of
serious infections in children (Brooks et al., 2005). We alsoor ZIP8 antibody and FITC-secondary conjugate.
ive cells within this population. The relative levels of
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observed that zinc supplementation significantly improves
survival in an animal model of combined zinc deficiency and
sepsis (Knoell et al., 2009). Further investigation is needed to
understand the complexity of zinc metabolism throughout the
entire course of sepsis before we are able to determine the
impact of zinc supplementation on patients with sepsis. Accu-
rate biomarkers that are predictive of zinc status will also be
required because plasma zinc levels are a poor indicator in the
setting of inflammation.
In conclusion, we report that the zinc transporter SLC39A8 is
a negative regulator of the NF-kB signaling pathway through
zinc-mediated suppression of IKK activity in monocytes, macro-
phages, and lung epithelia. In vivo, ZIP8 expression is induced
following innate immune activation and correlates with intracel-
lular zinc sequestration. We contend that these findings bridge
a fundamental gap in our understanding of how zincmetabolism,
or deficits therein, may critically influence the initial host
response to infection. In addition, they provide a framework for
understanding how inadequate zinc consumption can increase
risk of immune dysfunction, thereby compromising the host’s
capability to battle pathogens at the front line of defense.
EXPERIMENTAL PROCEDURES
Animal Studies
C57BL/6 mice (The Jackson Laboratory) were either injected (5 mg/g body
weight) intraperitoneally (i.p.) with LPS (Escherichia coli serotype 055:B5;
Sigma-Aldrich) or treated with CLP. To establish systemic zinc-deficiency
model, mice were randomly placed on a zinc-deficient diet (0.5–1.5 ppm
zinc) or a matched control diet (50.5–51.5 ppm zinc) for 3 weeks (Knoell
et al., 2009). All animal studies were conducted in accordance with the terms
and conditions of prior approval as set forth by The Ohio State University Insti-
tutional Animal Care and Use Committee.
Real-Time PCR
Quantitative PCR was performed using SYBR Green reagent (Applied Bio-
systems). Relative copy numbers (RCNs) of selected genes were normalized
to the expression of housekeeping genes (GAPDH or cyclophilin), then
calculated with the following equation: RCN = 2DCt 3 100, where DCt is the
Ct(target)  Ct(reference). PCR primers are listed in Table S1.
Promoter Cloning and Luciferase Assay
SLC39A8 luciferase reporter constructs were generated from human genomic
DNA using PCR amplification of an approximately 2,000 bp promoter
fragment, followed by insertion into pGL3 vector. Deletion constructs were
generated using a PCR-based subcloning strategy. Sequence analysis
confirmed the fidelity of all the constructs. Luciferase assay was performed
with Dual-Glo system (Promega). Cloning primers are listed in Table S1.
Western Blot, Immunoprecipitation, and Kinase Assay
Standard western blot and immunoprecipitation (IP) were performed. Kinase
assay was performed using the HTScan Kinase Assay Kit, with IkBa (Ser32)
peptide as the specific substrate (Cell Signaling Technology).
65Zinc-Blotting Assay
Protein samples were resolved by SDS-PAGE and transferred to a PVDF
membrane. Immunoblotting (IB) was first conducted using anti-iKKb antibody,
followed by intense stripping. Proteins on PVDF filter were renatured and incu-
bated with 100 mCi of 65ZnCl2. Autoradiography was then performed.
Zinc Measurement by Atomic Absorption Spectroscopy or
Inductively Coupled Plasma Optical-Emission Spectrometry
Solid tissues were dried, weighted, and digested in 1 ml mixed acid solution
(nitric acid:perchloric acid [1:2]) at 80C for 4–6 hr. Liquid samples were398 Cell Reports 3, 386–400, February 21, 2013 ª2013 The Authorsdigested with nitric acid (1%) for overnight. Samples were subjected to atomic
absorption spectroscopy (AAS) (AAnalyst 400; PerkinElmer) or a Vista-PRO
inductively coupled plasma optical-emission spectrometry (ICP-OES) (Varian).
Statistics
Data are representative of three independent experiments (mean ± SD or
SEM). Statistical comparisons among multiple groups were performed using
one-way ANOVA with Tukey’s or Dunnett’s post hoc test. Comparison among
four groupswith two factors was performed using 23 2 factorial ANOVA. Pairs
of treatment groups were compared using two-tailed unpaired Student’s t test.
Significance was assumed at a p value of less than 0.05 (*p < 0.05; n.s., not
significantly different).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, and Extended
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2013.01.009.
LICENSING INFORMATION
This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium,
provided the original author and source are credited.
ACKNOWLEDGMENTS
Dr. Denis Guttridge (The Ohio State University) provided the p65, p50, and
IkBa-SR plasmids. Drs. Michael Karin (University of California, San Diego)
and Ying Xia (University of Cincinnati) provided IKKb and NEMO knockout
MEFs. Technical support was provided by Catherine Powell, Dara Burris,
Chuan Yu, David Vera, and Bryan Lee. This work was supported by Lifeline
of Ohio Tissue Procurement Agency and the National Institutes of Health (HL
R01 HL086981-01 to D.L.K., T32 ES016646 to M.G.-P., and P30 ES06096
and R01 ES010416 to D.W.N.).
Received: July 26, 2012
Revised: November 28, 2012
Accepted: January 14, 2013
Published: February 7, 2013
REFERENCES
Abraham, E., and Singer, M. (2007). Mechanisms of sepsis-induced organ
dysfunction. Crit. Care Med. 35, 2408–2416.
Aiba, I., Hossain, A., and Kuo, M.T. (2008). Elevated GSH level increases
cadmium resistance through down-regulation of Sp1-dependent expression
of the cadmium transporter ZIP8. Mol. Pharmacol. 74, 823–833.
Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., and
Pinsky, M.R. (2001). Epidemiology of severe sepsis in the United States:
analysis of incidence, outcome, and associated costs of care. Crit. Care
Med. 29, 1303–1310.
Aydemir, T.B., Liuzzi, J.P., McClellan, S., and Cousins, R.J. (2009). Zinc trans-
porter ZIP8 (SLC39A8) and zinc influence IFN-gamma expression in activated
human T cells. J. Leukoc. Biol. 86, 337–348.
Banerjee, A., and Gerondakis, S. (2007). Coordinating TLR-activated signaling
pathways in cells of the immune system. Immunol. Cell Biol. 85, 420–424.
Banerjee, A., Gugasyan, R., McMahon, M., and Gerondakis, S. (2006). Diverse
Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase
(ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. USA 103, 3274–3279.
Bao, S., Liu, M.J., Lee, B., Besecker, B., Lai, J.P., Guttridge, D.C., and Knoell,
D.L. (2010). Zinc modulates the innate immune response in vivo to polymicro-
bial sepsis through regulation of NF-kappaB. Am. J. Physiol. Lung Cell. Mol.
Physiol. 298, L744–L754.
Begum, N.A., Kobayashi, M., Moriwaki, Y., Matsumoto, M., Toyoshima, K.,
and Seya, T. (2002). Mycobacterium bovis BCG cell wall and lipopolysaccha-
ride induce a novel gene, BIGM103, encoding a 7-TM protein: identification
of a new protein family having Zn-transporter and Zn-metalloprotease signa-
tures. Genomics 80, 630–645.
Besecker, B., Bao, S., Bohacova, B., Papp, A., Sadee, W., and Knoell, D.L.
(2008). The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated
cytoprotection in lung epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 294,
L1127–L1136.
Besecker, B.Y., Exline, M.C., Hollyfield, J., Phillips, G., Disilvestro, R.A.,
Wewers, M.D., and Knoell, D.L. (2011). A comparison of zinc metabolism,
inflammation, and disease severity in critically ill infected and noninfected
adults early after intensive care unit admission. Am. J. Clin. Nutr. 93, 1356–
1364.
Boone, D.L., Turer, E.E., Lee, E.G., Ahmad, R.C., Wheeler, M.T., Tsui, C., Hur-
ley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004). The ubiquitin-modi-
fying enzyme A20 is required for termination of Toll-like receptor responses.
Nat. Immunol. 5, 1052–1060.
Brooks, W.A., Santosham, M., Naheed, A., Goswami, D., Wahed, M.A.,
Diener-West, M., Faruque, A.S., and Black, R.E. (2005). Effect of weekly zinc
supplements on incidence of pneumonia and diarrhoea in children younger
than 2 years in an urban, low-income population in Bangladesh: randomised
controlled trial. Lancet 366, 999–1004.
Burns, K., Janssens, S., Brissoni, B., Olivos, N., Beyaert, R., and Tschopp, J.
(2003). Inhibition of interleukin 1 receptor/Toll-like receptor signaling through
the alternatively spliced, short form of MyD88 is due to its failure to recruit
IRAK-4. J. Exp. Med. 197, 263–268.
Caulfield, L.E., de Onis, M., Blo¨ssner, M., and Black, R.E. (2004). Undernutri-
tion as an underlying cause of child deaths associated with diarrhea, pneu-
monia, malaria, and measles. Am. J. Clin. Nutr. 80, 193–198.
Chiao, P.J., Miyamoto, S., and Verma, I.M. (1994). Autoregulation of I kappa B
alpha activity. Proc. Natl. Acad. Sci. USA 91, 28–32.
Cousins, R.J., and Leinart, A.S. (1988). Tissue-specific regulation of zinc
metabolism and metallothionein genes by interleukin 1. FASEB J. 2, 2884–
2890.
Cui, J., Zhu, L., Xia, X., Wang, H.Y., Legras, X., Hong, J., Ji, J., Shen, P., Zheng,
S., Chen, Z.J., andWang, R.F. (2010). NLRC5 negatively regulates the NF-kap-
paB and type I interferon signaling pathways. Cell 141, 483–496.
Gaetke, L.M., McClain, C.J., Talwalkar, R.T., and Shedlofsky, S.I. (1997).
Effects of endotoxin on zinc metabolism in human volunteers. Am. J. Physiol.
272, E952–E956.
Ga´lvez-Peralta, M., He, L., Jorge-Nebert, L.F., Wang, B., Miller, M.L., Eppert,
B.L., Afton, S., and Nebert, D.W. (2012). ZIP8 zinc transporter: indispensable
role for both multiple-organ organogenesis and hematopoiesis in utero.
PLoS One 7, e36055.
Girijashanker, K., He, L., Soleimani, M., Reed, J.M., Li, H., Liu, Z., Wang, B.,
Dalton, T.P., and Nebert, D.W. (2008). Slc39a14 gene encodes ZIP14,
a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol.
Pharmacol. 73, 1413–1423.
Haase, H., and Rink, L. (2007). Signal transduction in monocytes: the role of
zinc ions. Biometals 20, 579–585.
Haase, H., and Rink, L. (2009). Functional significance of zinc-related signaling
pathways in immune cells. Annu. Rev. Nutr. 29, 133–152.
Hambidge, K.M., and Krebs, N.F. (2007). Zinc deficiency: a special challenge.
J. Nutr. 137, 1101–1105.
Hayden, M.S., and Ghosh, S. (2008). Shared principles in NF-kappaB
signaling. Cell 132, 344–362.
Hotchkiss, R.S., and Karl, I.E. (2003). The pathophysiology and treatment of
sepsis. N. Engl. J. Med. 348, 138–150.
Jeon, K.I., Jeong, J.Y., and Jue, D.M. (2000). Thiol-reactive metal compounds
inhibit NF-kappa B activation by blocking I kappa B kinase. J. Immunol. 164,
5981–5989.CJohnson, G.L., and Lapadat, R. (2002). Mitogen-activated protein kinase
pathways mediated by ERK, JNK, and p38 protein kinases. Science 298,
1911–1912.
Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in
innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373–384.
Kehl-Fie, T.E., and Skaar, E.P. (2010). Nutritional immunity beyond iron: a role
for manganese and zinc. Curr. Opin. Chem. Biol. 14, 218–224.
King, J.C., Shames, D.M., and Woodhouse, L.R. (2000). Zinc homeostasis in
humans. J. Nutr. 130(5S, Suppl), 1360S–1366S.
Kitamura, H., Morikawa, H., Kamon, H., Iguchi, M., Hojyo, S., Fukada, T.,
Yamashita, S., Kaisho, T., Akira, S., Murakami, M., and Hirano, T. (2006).
Toll-like receptor-mediated regulation of zinc homeostasis influences
dendritic cell function. Nat. Immunol. 7, 971–977.
Knoell, D.L., Julian, M.W., Bao, S., Besecker, B., Macre, J.E., Leikauf, G.D.,
DiSilvestro, R.A., and Crouser, E.D. (2009). Zinc deficiency increases organ
damage and mortality in a murine model of polymicrobial sepsis. Crit. Care
Med. 37, 1380–1388.
Kobayashi, K., Hernandez, L.D., Gala´n, J.E., Janeway, C.A., Jr., Medzhitov, R.,
and Flavell, R.A. (2002). IRAK-M is a negative regulator of Toll-like receptor
signaling. Cell 110, 191–202.
Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., and Verma, I.M. (1999). Severe
liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284,
321–325.
Lichten, L.A., and Cousins, R.J. (2009). Mammalian zinc transporters: nutri-
tional and physiologic regulation. Annu. Rev. Nutr. 29, 153–176.
Liew, F.Y., Xu, D., Brint, E.K., and O’Neill, L.A. (2005). Negative regulation
of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5,
446–458.
Lin, W., Chai, J., Love, J., and Fu, D. (2010). Selective electrodiffusion of zinc
ions in a Zrt-, Irt-like protein, ZIPB. J. Biol. Chem. 285, 39013–39020.
Liuzzi, J.P., Lichten, L.A., Rivera, S., Blanchard, R.K., Aydemir, T.B., Knutson,
M.D., Ganz, T., and Cousins, R.J. (2005). Interleukin-6 regulates the zinc trans-
porter Zip14 in liver and contributes to the hypozincemia of the acute-phase
response. Proc. Natl. Acad. Sci. USA 102, 6843–6848.
Martin, G.S., Mannino, D.M., Eaton, S., and Moss, M. (2003). The epidemi-
ology of sepsis in the United States from 1979 through 2000. N. Engl. J.
Med. 348, 1546–1554.
Nishida, K., Hasegawa, A., Nakae, S., Oboki, K., Saito, H., Yamasaki, S., and
Hirano, T. (2009). Zinc transporter Znt5/Slc30a5 is required for the mast cell-
mediated delayed-type allergic reaction but not the immediate-type reaction.
J. Exp. Med. 206, 1351–1364.
Parrillo, J.E. (1993). Pathogenetic mechanisms of septic shock. N. Engl. J.
Med. 328, 1471–1477.
Prasad, A.S., Beck, F.W., Bao, B., Fitzgerald, J.T., Snell, D.C., Steinberg, J.D.,
and Cardozo, L.J. (2007). Zinc supplementation decreases incidence of infec-
tions in the elderly: effect of zinc on generation of cytokines and oxidative
stress. Am. J. Clin. Nutr. 85, 837–844.
Rink, L., and Haase, H. (2007). Zinc homeostasis and immunity. Trends Immu-
nol. 28, 1–4.
Rudolph, D., Yeh,W.C.,Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J.,
Elia, A.J., and Mak, T.W. (2000). Severe liver degeneration and lack of NF-
kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14,
854–862.
Ruland, J. (2011). Return to homeostasis: downregulation of NF-kB
responses. Nat. Immunol. 12, 709–714.
Sobocinski, P.Z., Canterbury, W.J., Jr., Mapes, C.A., and Dinterman, R.E.
(1978). Involvement of hepatic metallothioneins in hypozincemia associated
with bacterial infection. Am. J. Physiol. 234, E399–E406.
Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflam-
mation. Cell 140, 805–820.
Thomas, L. (1972). Germs. N. Engl. J. Med. 287, 553–555.ell Reports 3, 386–400, February 21, 2013 ª2013 The Authors 399
Wang, B., He, L., Dong, H., Dalton, T.P., and Nebert, D.W. (2011). Generation
of a Slc39a8 hypomorph mouse: markedly decreased ZIP8 Zn2+/(HCO3
)2
transporter expression. Biochem. Biophys. Res. Commun. 410, 289–294.
Warren, H.S. (1997). Strategies for the treatment of sepsis. N. Engl. J. Med.
336, 952–953.
Waterfield, M., Jin, W., Reiley, W., Zhang, M., and Sun, S.C. (2004). IkappaB
kinase is an essential component of the Tpl2 signaling pathway. Mol. Cell.
Biol. 24, 6040–6048.
Wong, H.R., Shanley, T.P., Sakthivel, B., Cvijanovich, N., Lin, R., Allen, G.L.,
Thomas, N.J., Doctor, A., Kalyanaraman, M., Tofil, N.M., et al.; Genomics of400 Cell Reports 3, 386–400, February 21, 2013 ª2013 The AuthorsPediatric SIRS/Septic Shock Investigators (2007). Genome-level expression
profiles in pediatric septic shock indicate a role for altered zinc homeostasis
in poor outcome. Physiol. Genomics 30, 146–155.
Xu, G., Lo, Y.C., Li, Q., Napolitano, G., Wu, X., Jiang, X., Dreano, M., Karin, M.,
and Wu, H. (2011). Crystal structure of inhibitor of kB kinase b. Nature 472,
325–330.
Yu, M., Lee, W.W., Tomar, D., Pryshchep, S., Czesnikiewicz-Guzik, M., Lamar,
D.L., Li, G., Singh, K., Tian, L., Weyand, C.M., and Goronzy, J.J. (2011). Regu-
lation of T cell receptor signaling by activation-induced zinc influx. J. Exp.Med.
208, 775–785.
